Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2012 / Article

Research Article | Open Access

Volume 2012 |Article ID 513068 | 7 pages | https://doi.org/10.1155/2012/513068

Cinnamomi ramulus Ethanol Extract Exerts Vasorelaxation through Inhibition of Influx and Release in Rat Aorta

Academic Editor: David Baxter
Received04 Mar 2011
Accepted15 May 2011
Published13 Jul 2011


Contraction of vascular smooth muscle cells depends on the induction of cytosolic calcium ion (Ca2+) due to either Ca2+ influx through voltage-gated Ca2+ channels or to receptor-mediated Ca2+ release from the sarcoplasmic reticulum. The present study investigated the vasorelaxation effect of Cinnamomi ramulus ethanol extract (CRE) and the possible mechanisms in rat aorta. CRE (0.1 mg/mL) relaxed vasoconstriction induced by phenylephrine (PE; 1 μM) and angiotensin II (5 μM). Preincubation with CRE significantly reduced the rat aortic contraction by addition of CaCl2 in Ca2+-free Krebs solution and FPL64176 (10 μM). Pretreatment with nifedipine (100 μM) or verapamil (1 μM) significantly reduced the CRE-mediated vasorelaxation of PE-induced vascular contraction. In addition, CRE also relaxed the vascular contraction caused by m-3M3FBS (5 μg/mL), but U73122 (10 μM) significantly inhibited the vasorelaxation of PE precontracted aortic rings. Furthermore, CRE significantly reduced the magnitude of PE- and caffeine (30 mM)-induced transient contraction. In vascular strips, CRE downregulated the expression levels of phosphorylated PLC and phosphoinositide 3-kinase elevated by PE or m-3M3FBS. These results suggest that CRE relaxes vascular smooth muscle through the inhibition of both Ca2+ influx via L-type Ca2+ channel and inositol triphosphate-induced Ca2+ release from the sarcoplasmic reticulum.

1. Introduction

Increasing cytosolic calcium ion (Ca2+) concentration is essential for the contraction of smooth muscle cells. The increase results from the influx of Ca2+ through the plasma membrane and release of Ca2+ from intracellular stores, mainly the sarcoplasmic reticulum (SR) [14].

Phenylephrine (PE) or angiotensin II (Ang II) induces receptor-coupled G protein-induced phosphoinositide 3-kinase (PI3K) and phospholipase C (PLC) activation, resulting in Ca2+-dependent vasoconstriction in smooth muscle cells [510]. PI3K activity facilitates the production of 3-phosphorylated phosphoinositides such as phosphatidylinositol 3-phosphate (PI(3)P), phosphatidylinositol (3,4)-bisphosphate (PI(3,4)P2), and phosphatidylinositol (3,4,5)-triphosphate (PI(3,4,5)P3) [11, 12]. Among these, PI(3,4,5)P3 stimulates the L-type Ca2+ channel (12), a voltage-dependent Ca2+ channel that plays an important role in the regulation of vascular tone [5, 12, 13]. Activated PLC is an effector in the stimulation of Ca2+ release from the endoplasmic reticulum (ER) or the SR [1416]. PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into diacylglycerol (DAG) and inositol (3, 4, 5)-triphosphate (IP3) [14]. The latter is released as a soluble structure into the cytosol, where it binds to IP3 receptors in the SR [15, 17]. This binding process increases the cytosolic Ca2+ concentration and smooth muscle constriction [15, 16].

The herb Cinnamomi ramulus (CR) has traditionally been used in Asia and Europe to treat maladies involving blood circulation and inflammation. In one study, an aqueous extract of CR ameliorated sucrose-induced blood pressure elevation in spontaneously hypertensive rats [18]. Recently, we reported that CR ethanol extract (CRE) reduces vascular contraction through the inhibition of voltage-dependent Ca2+ channels [19]. However, the possible mechanisms of CRE were not elucidated. The present study explored the suggestion that the vasodilatory effect of CRE is related to Ca2+-dependent mechanisms in rat aorta.

2. Materials and Methods

2.1. Materials

Male Sprague-Dawley rats weighing 320–350 g were used for all experiments. All animals were provided with food and water ad libitum and allowed to adapt to the experimental conditions (temperature, °C; humidity, 50–60%) for 1 week. Rabbit polyclonal antibodies against phosphorylated PLC (pPLC), β-actin, and anti-rabbit secondary antibody were purchased from Santa Cruz Biotechnology (Santa Cruz, Calif, USA). PI3K/p85 antibody was purchased from Cell Signaling Technology (Beverly, Mass, USA). PE, Ang II, verapamil, nifedipine, FPL64176, 2, 4, 6-trimethyl-N-(meta-3-trifluoromethyl-phenyl)-benzenesulfonamide (m-3M3FBS), U73122 and caffeine were purchased from Sigma-Aldrich (St. Louis, Mo, USA). PE, Ang II, nifedipine, and verapamil were dissolved in distilled water. FPL64176, U73122, m-3M3FBS, and caffeine were prepared in dimethylsulfoxide. All drugs were diluted in Krebs solution in the organ bath.

2.2. Plant Material

CR (twigs of Cinnamomum cassia Blume) collected in China in November 2009 was purchased from Humanherb (Gyeongsan, Korea). The identity of the purchased material was verified by H.M. Shin (College of Oriental Medicine, Dongguk University, Gyeongju, Korea). A voucher specimen (CRE08) has been deposited in the College of Oriental Medicine, Dongguk University.

2.3. Preparation of CRE

Dried CR (100 g) was extracted with 500 mL of 70% ethanol by heating at 75°C for 3 h. The extract was filtered through Whatman filter paper (Whatman International, Maidstone, UK) to remove the insoluble materials. After filtration, the extracts were concentrated by rotary evaporation using a model VV2000 apparatus (Heidolph, Walpersdorfer, Germany) at a temperature of 75°C and then dried using a model FD8508S freeze dryer (Ilshin, Busan, Korea). The yield of dry matter from the extracts was approximately 2.1%. The material was stored at 4°C until use. The EC50 value of 0.1 mg/mL CRE was used in all experiments. In a previous research [20], cinnamaldehyde and coumarin were analyzed as main compounds of CRE by gas chromatography-mass spectrometry. Also, cinnamaldehyde was known as major active compound of CR for vasodilation, antitumor, and antifungal activity.

2.4. Preparation of Thoracic Aortic Rings

All procedures were performed according to protocols approved by the Institutional Animal Care and Use Committee of Dongguk University. A previously described procedure [21] was employed with some modification. Briefly, rats were sacrificed and their thoracic aortas were immediately excised and immersed in ice-cold Krebs solution (115.0 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM MgCl2, 25.0 mM NaHCO3, 1.2 mM KH2PO4, and 10.0 mM dextrose). The aortas were cleaned of all adherent connective tissue and cut into 3 mm long ring segments. Endothelium was removed from the internal surface of each segment by gentle rubbing with forceps.

2.5. Organ Bath Study

Tension was measured by a modification of a previously described procedure [22]. Briefly, two stainless-steel triangles were inserted through each vessel ring. One triangle was anchored to a stationary support and the other was connected to a FT03 isometric force transducer (Grass, Quincy, Mass, USA). Each vessel ring was incubated in a water-jacketed organ bath (10 mL) that was maintained at 37°C and aerated with a mixture of 95% O2 and 5% CO2. Each ring was stretched passively by imposing the optimal resting tension of approximately 2.0 g, which was maintained throughout the experiment. Each endothelium-free aortic ring was allowed to equilibrate in the organ bath for at least 50 min before the experiment involving the contractile response to 5 μM Ang II, 1 μM PE, 10 μM FPL64176, 5 μg/mL m-3M3FBS, or 30 mM caffeine. Endothelium-free rings were used because preliminary experiments (data not shown) established that CRE relaxes vascular constriction in an endothelium-independent manner. The denudation of endothelium was assessed by treating the rings with 1 μM acetylcholine. Isometric tension was recorded using a PowerLab/8SP computerized data acquisition system (ADInstruments, Castle Hill, NSW, Australia). The influence of CRE on extracellular Ca2+ influx was studied in Ca2+-free Krebs solution. After equilibration of the ring in Ca2+-free Krebs solution containing 60 mM KCl, cumulative doses of CaCl2 were added (0.3, 0.6, 1, 1.5, 2.5, 5, and 10 mM, in order) with preincubation of CRE in organ bath. The CaCl2 dose-dependent maximum constriction of the aortic ring with 60 mM KCl in Ca2+-free Krebs solution was expressed as 100%. To determine the influence of CRE on Ca2+ influx through the L-type Ca2+ channel, aortic rings were pretreated with nifedipine or verapamil before PE contraction, and were preincubated with CRE before contraction by FPL64176. To investigate the inhibitory effect of CRE on intracellular Ca2+ release by PE in Ca2+-free conditions, and by caffeine in normal Krebs solution, the transient contraction of CRE preincubated aortic rings was measured. To further investigate the relationship with the PLC pathway, aortic rings were constricted with m-3M3FBS, and were preincubated with U73122 prior to contraction by PE. When the constriction reached a plateau, CRE was added to the organ bath.

2.6. Preparation of Aorta Protein Extracts and Western Blot Analysis

A previously described protocol [22] was used for preparation of protein extract with some modifications. Briefly, endothelium-free aortic rings were contracted with 1 μM PE or 5 μg/mL m-3M3FBS, and then treated with CRE for 30 min. The aortic rings were quick frozen by immersion in acetone containing 10% trichloroacetic acid (TCA) and 10 mM dithiothreitol (DTT) precooled to −80°C. When used, recovered samples were homogenized in buffer containing 320 mM sucrose, 50 mM Tris, 1 mM EDTA, 1% Triton X-100, 1 mM DTT, and the following protease inhibitors: leupeptin (10 μg/mL), trypsin (10 μg/mL), aprotinin (2 μg/mL), or phenylmethylsulphonyl fluoride (100 μg/mL). The protein samples were electrophoresed and the resolved proteins were transferred to a nitrocellulose membrane. The membrane was incubated with primary antibodies and then treated with horseradish peroxidase-conjugated anti-rabbit IgG as a secondary antibody. All bands were detected using an enhanced chemiluminescence system (Amersham Biosciences, Buckinghamshire, UK).

2.7. Statistical Analyses

Each set of experiments was done at least three times and results are presented as the mean ± SD. The statistical significance of differences between mean values was assessed with Student’s t-test or ANOVA. Test values that resulted in were considered as significant.

3. Results

3.1. Vasorelaxation Effect of CRE on PE- or Ang II-induced Constricted Aorta

Ang II increases the intracellular Ca2+ concentration in vascular smooth muscle cells through a sequence of events following activation of Ang II type 1 receptor and L-type calcium channels [6, 7]. PE- or Ang II-induced contraction was significantly dilated by and , respectively, as compared to maximal tension (Figure 1), indicating that that CRE-mediated vasodilation may be related to decreased intracellular Ca2+ concentration.

3.2. Effects of CRE on Ca2+ Influx from the Extracellular Space

To determine the influence of CRE on Ca2+ influx, the change of contraction was measured by adding CaCl2 in an accumulative manner (0.3, 0.6, 1, 1.5, 2.5, 5, and 10 mM, in order) before and after CRE pretreatment in Ca2+-free Krebs solution containing 60 mM KCl. The vasoconstriction rate at the aforementioned CaCl2 concentrations were , , , , , , and 100%, respectively, (the latter represents the maximum contraction value of the aortic ring, achieved at 10 mM CaCl2). These contractions were significantly reduced by , , , , , , and (same respective CaCl2 concentrations) with CRE-pretreatment (Figure 2).

3.3. Effect of CRE on Ca2+ Influx through L-type Ca2+-Channels

To discern the effect of CRE on the L-type calcium channel, the influence of the L-type calcium channel blocker nifedipine (100 μM) or verapamil (1 μM), and the L-type calcium channel activator FPL64176 (10 μM) on vasorelaxation of CRE against PE-induced contraction of aortic rings was measured. Pretreatment of aortic rings with nifedipine or verapamil significantly inhibited the relaxant effect of CRE (Figure 3(a)). Previous studies have shown that FPL64176 increases extracellular Ca2+ entry, thereby enhancing the cytosolic Ca2+ concentration [23, 24]. Presently, FPL64176 induced contraction, which plateaued at  g in 30 min, was inhibited by  g with preincubation of CRE (Figure 3(b)).

3.4. Effect of CRE on Ca2+ Release from SR

To assess whether CRE is involved in Ca2+ release-mediated vasoconstriction from intracellular stores, the transient contraction by PE or caffeine was examined in CRE preincubated aortic rings. Preincubation reduced the magnitude of contraction by PE from  g to  g (Figure 4(a)). The transient contraction induced by 30 mM caffeine was also reduced by CRE pretreatment (Figure 4(b)).

3.5. Effect of CRE on PLC Pathway

To evaluate whether the relaxant effect of CRE was involved in the PLC pathway, the PLC pathway inhibitor U73122 and activator m-3M3FBS were used. U73122 pretreatment significantly inhibited the relaxant effect of CRE on PE-induced contraction from to (Figure 5(a)). m-3M3FBS (5 μg/mL)-induced contraction was relaxed significantly with CRE treatment (Figure 5(b)).

3.6. Effect of CRE on the Expression Levels of PI3K and pPLC

PI3K is directly activated by G-protein for generation of PIP3, which eventually stimulates L-type calcium channels in vascular myocytes [5, 12]. PLC activation induces the generation of IP3 and DAG. In turn, IP3 stimulates intracellular Ca2+ release from the SR for vasoconstriction [15, 17]. Presently, PE and m-3M3FBS increased the expression levels of PI3K ( and , resp.) and pPLC ( and , resp.), which were significantly decreased by CRE. PE-induced PI3K expression was decreased by at 50 μg/mL and by at 100 μg/mL. pPLC expression was also decreased by at 50 μg/mL and by at 100 μg/mL (Figure 6(a)). m-3M3FBS-induced PI3K expression was downregulated by at 50 μg/mL and by at 100 μg/mL, and pPLC expression was decreased by at 50 μg/mL and by at 100 μg/mL (Figure 6(b)).

4. Discussion and Conclusions

Traditionally, Cinnamomum cassia has been used as a medicinal herb. Its bark and twig are known as Cinnamomi cortex (CC) and Cinnamomi ramulus (CR), respectively. CC inhibits Helicobacter pylori [25] and ameliorates sucrose-induced blood pressure elevation in spontaneously hypertensive rats [18]. Furthermore, CRE exerts an endothelium-independent vasodilatory response through inhibition of voltage-dependent Ca2+ channels [19]. However, the mechanism by which CR exerts vasodilation remains to be elucidated. The present study investigated the vasodilatory effect of CRE resulting from the inhibition of both Ca2+ influx and release in rat aorta.

PE or Ang II stimulate PLC isoforms to generate IP3 through the activation of G proteins, causing release of activator Ca2+ from SR [9, 10, 1416]. Presently, CRE markedly and similarly relaxed aortic rings that were precontracted with PE or AngII. These results suggest that CRE-mediated vasodilation may be involved in the regulation of Ca2+ mobilization. To assess this, the regulation of Ca2+ influx and release was investigated. Firstly, whether CRE actually inhibits extracellular Ca2+ influx or not, we measured the tension of aortic rings by accumulative addition of CaCl2 in Ca2+-free Krebs solution containing 60 mM KCl. Preincubation with CRE significantly reduced rat aortic contraction by addition of CaCl2,, indicating inhibition of Ca2+ influx. Nifedipine (100 μM) and verapamil (1 μM) pretreatment inhibited the vasodilative effect of CRE on PE-induced constricted aortic rings from to and , respectively. In addition, preincubation with CRE reduced the contraction of aortic ring by 10 μM FPL64176. These results support the suggestion that the vasodilative effect of CRE is related to the inhibition of L-type calcium channel in the cell membrane.

The SR is the major source of Ca2+ release into the cytosol [1, 16, 17]. This Ca2+ release is induced by the IP3 second messenger, which is generated by PLC activation [17]. Ca2+ release from the SR is considered to be the initial mechanism in agonists such as PE- and Ang II-induced vasoconstriction [6, 17]. PE-induced transient constriction is dependent on Ca2+ release from the SR through the IP3 signal pathway in Ca2+-free Krebs solution [26]; however, caffeine is dependent on Ca2+-induced Ca2+ release from the SR [27, 28]. To demonstrate the effects of CRE on Ca2+ release from the SR, transient contractions induced by PE in Ca2+-free Krebs solution and induced by caffeine in normal Krebs solution were investigated. CRE significantly reduced the magnitudes of transient contraction by PE and caffeine, suggesting CRE inhibits Ca2+ release from the SR by blocking the IP3-induced Ca2+ release and Ca2+-induced Ca2+ release mechanisms.

Pretreatment with the PLC inhibitor U73122 significantly reduced the vasorelaxation of CRE on PE-induced vasoconstriction, and CRE relaxed m-3M3FBS-induced vasoconstriction. Additionally, we analyzed the expression levels of the intracellular signaling regulator proteins PI3K and PLC. PI3K generates various 3-phosphorylated phosphoinositides through activation by G-proteins, especially PI(3,4,5)P3 stimulates the L-type Ca2+ channel that plays an important role in the regulation of vascular tone [8, 11, 12]. On the other hand, PLC formats the two potent second messengers IP3 and DAG. Especially, IP3 induces the activation of IP3 receptor on the SR membrane, opening a calcium channel, resulting in the release of Ca2+ into the cytosol [14, 17]. Presently, PE- or m-3M3FBS-induced phosphorylation of PLC and upregulation of PI3K/p85 protein expression were inhibited by CRE (Figure 6). The collective data supports the idea that CRE dilates vascular contraction through the inhibition of both Ca2+ influx via the L-type Ca2+ channel and IP3-induced Ca2+ release from the SR.

In conclusion, the data supports the vasorelaxation of CRE through the inhibition of Ca2+ influx and Ca2+ release. Therefore, CRE may be useful as a drug for the treatment and prevention of high blood pressure associated with Ca2+-dependent contraction of smooth muscle.


This work was supported by General Research Grants of Ministry of Education, Science, and Technology (no. 20090073977) and the Dongguk University Research Fund of 2010.


  1. A. P. Albert, S. N. Saleh, C. M. Peppiatt-Wildman, and W. A. Large, “Multiple activation mechanisms of store-operated TRPC channels in smooth muscle cells,” The Journal of Physiology, vol. 583, part 1, pp. 25–36, 2007. View at: Publisher Site | Google Scholar
  2. L. J. Janssen, “Ionic mechanisms and Ca2+ regulation in airway smooth muscle contraction: do the data contradict dogma?” American Journal of Physiology, vol. 282, no. 6, pp. L1161–L1178, 2002. View at: Google Scholar
  3. M. J. Berridge, “Smooth muscle cell calcium activation mechanisms,” The Journal of Physiology, vol. 586, part 21, pp. 5047–5061, 2008. View at: Publisher Site | Google Scholar
  4. V. Bito, F. R. Heinzel, L. Biesmans, G. Antoons, and K. R. Sipido, “Crosstalk between L-type Ca2+ channels and the sarcoplasmic reticulum: alterations during cardiac remodelling,” Cardiovascular Research, vol. 77, no. 2, pp. 315–324, 2008. View at: Publisher Site | Google Scholar
  5. K. H. Do, M. S. Kim, J. H. Kim et al., “Angiotensin II-induced aortic ring constriction is mediated by phosphatidylinositol 3-kinase/L-type calcium channel signaling pathway,” Experimental ' Molecular Medicine, vol. 41, no. 8, pp. 569–576, 2009. View at: Publisher Site | Google Scholar
  6. B. M. Wynne, C. W. Chiao, and R. C. Webb, “Vascular smooth muscle cell signaling mechanisms for contraction to angiotensin II and endothelin-1,” Journal of the American Society of Hypertension, vol. 3, no. 2, pp. 84–95, 2009. View at: Publisher Site | Google Scholar
  7. A. J. Fuller, B. C. Hauschild, R. Gonzalez-Villalobos et al., “Calcium and chloride channel activation by angiotensin II-AT1 receptors in preglomerular vascular smooth muscle cells,” American Journal of Physiology, vol. 289, no. 4, pp. F760–F767, 2005. View at: Publisher Site | Google Scholar
  8. P. Viard, T. Exner, U. Maier, J. Mironneau, B. Nürnberg, and N. Macrez, “Gbetagamma dimers stimulate vascular L-type Ca2+ channels via phosphoinositide 3-kinase,” The FASEB Journal, vol. 13, no. 6, pp. 685–694, 1999. View at: Google Scholar
  9. N. S. Andrawis, N. Craft, and D. R. Abernethy, “Calcium antagonists block angiotensin II-mediated vasoconstriction in humans: comparison with their effect on phenylephrine-induced vasoconstriction,” The Journal of Pharmacology and Experimental Therapeutics, vol. 261, no. 3, pp. 879–884, 1992. View at: Google Scholar
  10. D. R. Varma and X. F. Deng, “Cardiovascular α1-adrenoceptor subtypes: functions and signaling,” Canadian Journal of Physiology and Pharmacology, vol. 78, no. 4, pp. 267–292, 2000. View at: Google Scholar
  11. S. J. Leevers, B. Vanhaesebroeck, and M. D. Waterfield, “Signalling through phosphoinositide 3-kinases: the lipids take centre stage,” Current Opinion in Cell Biology, vol. 11, no. 2, pp. 219–225, 1999. View at: Publisher Site | Google Scholar
  12. C. Le Blanc, C. Mironneau, C. Barbot et al., “Regulation of vascular L-type Ca2+ channels by phosphatidylinositol 3,4,5-trisphosphate,” Circulation Research, vol. 95, no. 3, pp. 300–307, 2004. View at: Publisher Site | Google Scholar
  13. R. Treinys and J. Jurevicius, “L-type Ca2+ channels in the heart: structure and regulation,” Medicina, vol. 44, no. 7, pp. 491–499, 2008. View at: Google Scholar
  14. P. G. Suh, J. I. Park, L. Manzoli et al., “Multiple roles of phosphoinositide-specific phospholipase C isozymes,” Journal of Biochemistry and Molecular Biology, vol. 41, no. 6, pp. 415–434, 2008. View at: Google Scholar
  15. J. W. Putney Jr., L. M. Broad, F. J. Braun, J. P. Lievremont, and G. S. Bird, “Mechanisms of capacitative calcium entry,” Journal of Cell Science, vol. 114, part 12, pp. 2223–2229, 2001. View at: Google Scholar
  16. J. Ureña, A. del Valle-Rodríguez, and J. López-Barneo, “Metabotropic Ca2+ channel-induced calcium release in vascular smooth muscle,” Cell Calcium, vol. 42, no. 4-5, pp. 513–520, 2007. View at: Publisher Site | Google Scholar
  17. Q. Xi, A. Adebiyi, G. Zhao et al., “IP3 constricts cerebral arteries via IP3 receptor-mediated TRPC3 channel activation and independently of sarcoplasmic reticulum Ca2+ release,” Circulation Research, vol. 102, no. 9, pp. 1118–1126, 2008. View at: Publisher Site | Google Scholar
  18. H. G. Preuss, B. Echard, M. M. Polansky, and R. Anderson, “Whole cinnamon and aqueous extracts ameliorate sucrose-induced blood pressure elevations in spontaneously hypertensive rats,” Journal of the American College of Nutrition, vol. 25, no. 2, pp. 144–150, 2006. View at: Google Scholar
  19. J. B. Kim and H. M. Shin, “Vasodilation of ethanol extract of Cinnamomi Ramulus via voltage dependent Ca2+ channel blockage,” Korean Journal of Oriental Physiology and Pathology, vol. 24, no. 4, pp. 592–597, 2010. View at: Google Scholar
  20. H. J. Park, J. S. Lee, J. D. Lee et al., “The anti-inflammatory effect of Cinnamomi Ramulus,” Journal of Korean Oriental Medicine, vol. 26, no. 2, pp. 140–151, 2005. View at: Google Scholar
  21. S. B. Jeon, G. Kim, J. I. Kim et al., “Flavone inhibits vascular contraction by decreasing phosphorylation of the myosin phosphatase target subunit,” Clinical and Experimental Pharmacology & Physiology, vol. 34, no. 11, pp. 1116–1120, 2007. View at: Publisher Site | Google Scholar
  22. S. B. Jeon, F. Jin, J. I. Kim et al., “A role for Rho kinase in vascular contraction evoked by sodium fluoride,” Biochemical and Biophysical Research Communications, vol. 343, no. 1, pp. 27–33, 2006. View at: Publisher Site | Google Scholar
  23. J. S. Fan and P. Palade, “Effects of FPL 64176 on Ca transients in voltage-clamped rat venticular myocytes,” British Journal of Pharmacology, vol. 135, no. 6, pp. 1495–1504, 2002. View at: Google Scholar
  24. Y. S. Bae, T. G. Lee, J. C. Park et al., “Identification of a compound that directly stimulates phospholipase C activity,” Molecular Pharmacology, vol. 63, no. 5, pp. 1043–1050, 2003. View at: Publisher Site | Google Scholar
  25. Y. Nir, I. Potasman, E. Stermer, M. Tabak, and I. Neeman, “Controlled trial of the effect of cinnamon extract on Helicobacter pylori,” Helicobacter, vol. 5, no. 2, pp. 94–97, 2000. View at: Publisher Site | Google Scholar
  26. A. M. Gurney and M. Allam, “Inhibition of calcium release from the sarcoplasmic reticulum of rabbit aorta by hydralazine,” British Journal of Pharmacology, vol. 114, no. 1, pp. 238–244, 1995. View at: Google Scholar
  27. H. Shima and M. P. Blaustein, “Modulation of evoked contractions in rat arteries by ryanodine, thapsigargin, and cyclopiazonic acid,” Circulation Research, vol. 70, no. 5, pp. 968–977, 1992. View at: Google Scholar
  28. H. Y. Ahn, H. Karaki, and N. Urakawa, “Inhibitory effects of caffeine on contractions and calcium movement in vascular and intestinal smooth muscle,” British Journal of Pharmacology, vol. 93, no. 2, pp. 267–274, 1988. View at: Google Scholar

Copyright © 2012 Yun Hwan Kang and Heung Mook Shin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

1055 Views | 577 Downloads | 4 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.